Human CD8+ T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in the Gambia

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 7144-7148

  Smith, Steven M ^a   Klein, Michèl R ^b   Malin, Adam S ^a   Sillah, Jackson ^b   Huygen, Kris ^c   Andersen, Peter ^d   McAdam, Keith P W J ^b   Dockrell, Hazel M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; PERFORIN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; GAMBIA; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; BCG VACCINE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MYCOBACTERIUM TUBERCULOSIS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS; VACCINATION;

EID: 0034442795     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.7144-7148.2000     Document Type: Article

References (26)

1. Andersen, P., A. B. Andersen, A. L. Sorensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
2. + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J. Immunol. 162:327-379.
3. Cooper, A. M., C. D'Souza, A. A. Frank, and I. M. Orme. 1997. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perform-or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65:1317-1320.
4. Denis, O., E. Lozes, and K. Huygen. 1997. Induction of cytotoxic-T-cell responses against culture nitrate antigens in Mycobacterium bovis Bacillus Calmette-Guerin-infected mice. Infect. Immun. 65:676-684.
5. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66: 1527-1533.
6. b mice. Int. Immunol. 11:209-216.
7. Fine, P. E., and L. C. Rodrigues. 1990. Modern vaccines: mycobacterial disease. Lancet 335:1016-1020.
8. Flynn, J.-A. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mvcobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-12017.
9. Gong, J., S. Stenger, J. A. Zack, B. E. Jones, G. C. Bristol, R. L. Modlin, P. J. Morrissey, and P. F. Barnes. 1998. Isolation of Mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection. J. Clin. Investig. 101:383-389.
10. Harboe, M., A. S. Malin, H. M. Dockrell, H. G. Winker, G. Ulvund, A. Holm, M. C. Jorgensen, and P. Andersen. 1998. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect. Immun. 66: 717-723.
11. Harboe, M., T. Oettinger, H. G. Winker, I. Rosenkrands, and P. Andersen. 1996. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobaclerium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64:16-22.
12. Ladel, C. H., S. Daugelat, and S. H. E. Kaufmann. 1995. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I-and II-deficient knock-out mice: contribution of CD4 and CDS T cells to acquired resistance. Eur. J. Immunol. 25:377-384.
13. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:270-275.
14. Laochumroonvorapong, P., J. Wang, C.-C. Liu, W. Ye, A. L. Moreira, K. B. Elkon, V. H. Freedman, and G. Kaplan. 1997. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 65:127-132.
15. + T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 187:1633-1640.
16. Mohagheghpour, N., D. Gammon, L. M. Kawamura, A. van Vollenhnven, C. J. Benike, and E. G. Engleman. 1998. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J. Immunol. 161:2400-2406.
17. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell responses to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481.
18. Raviglione, M. C., D. E. J. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 273:220-226.
19. Ravn, P., A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H. A. Amoudy, A. S. Mustafa, A. K. Jensen, A. Holm, I. Rosenkrands, F. Oftung, J. Olobo, F. von Reyn, and P. Andersen. 1999. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179:637-645.
20. + αβ T cell pool. J. Immunol. 162:366-371.
21. + T cells. Infect. Immun. 67:5223-5230.
22. + cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J. Immunol. 159:290-297.
23. + T cells in vitro. Immunology 87:339-342.
24. Ulrichs, T., M. E. Munk, H. Mollenkopf, S. Behr-Perst, R. Colangeli, M. L. Gennaro, and S. H. E. Kaufmann. 1998. Differential T cell responses to Mycobacterium tuberculosis ESAT-6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 28:3949-3958.
25. Zhu, X., N. Venkataprasad, J. Ivanyi, and H. M. Vordermeier. 1997. Vaccination with recombinant vaccinia virus protects mice against Mycobacterium tuberculosis infection. Immunology 92:6-9.
26. b mice recognising the 38-kDa antigen of Mycobacterium tuberculosis. Int. Immunol. 9:1669-1676.